Page last updated: 2024-08-20

nitrilotriacetic acid and Mast-Cell Sarcoma

nitrilotriacetic acid has been researched along with Mast-Cell Sarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altin, JG; Parish, CR; van Broekhoven, CL; Vassiliou, G1

Other Studies

1 other study(ies) available for nitrilotriacetic acid and Mast-Cell Sarcoma

ArticleYear
Engrafting costimulator molecules onto tumor cell surfaces with chelator lipids: a potentially convenient approach in cancer vaccine development.
    Journal of immunology (Baltimore, Md. : 1950), 2000, Mar-01, Volume: 164, Issue:5

    Topics: Amines; Animals; B7-1 Antigen; Cancer Vaccines; CD40 Antigens; Cell Division; Cell Membrane; Chelating Agents; Cytotoxicity, Immunologic; Female; Histidine; Lymphocyte Activation; Male; Mast-Cell Sarcoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microscopy, Confocal; Nitrilotriacetic Acid; Protein Binding; T-Lymphocytes; Tumor Cells, Cultured

2000